Algae4IBD

Algae4IBD is dedicated to pioneering innovative research services focused on harnessing the therapeutic potential of algae to combat pain, inflammation, and inflammatory bowel disease (IBD). Algae4IBD is committed to identifying and cultivating various algae species to discover compounds that can alleviate pain and inflammation, driving the development of novel functional foods and medications. By bringing these health benefits from the ocean to people, Algae4IBD aims to address the critical needs of the over 6.8 million children and adults globally affected by IBD, encompassing ulcerative colitis and Crohn’s disease.

Located at MIGAL Building, Southern Industrial Zone, Tarshish St., Qiryat Shemona, IL, Algae4IBD operates as a partnership, furthering its mission through rigorous research and development. With a focus on creating effective alternatives to current treatments that may not work for everyone, Algae4IBD is at the forefront of innovative healthcare solutions. The company's H2020-funded project (101000501) underscores its dedication to advancing scientific breakthroughs in the field.

Algae4IBD stands as a beacon of hope for those seeking relief from IBD and related conditions. The company’s commitment to research, development, and innovative solutions makes it a key player in the future of healthcare. We invite the manager of Algae4IBD to create a customized and exclusive company showcase and product listing on our platform to further highlight your groundbreaking work.